Ras-interacting protein 1
Ras-interacting protein 1 (RasIP1), also known as Rasip1, is a protein that in humans is encoded by the RASIP1 gene. This protein plays a crucial role in cell signaling pathways that are essential for cell growth, cell differentiation, and the maintenance of cell shape and mobility. RasIP1 is particularly significant in the context of its interaction with members of the Ras superfamily of small GTPases, which are pivotal in various cellular processes.
Function[edit | edit source]
RasIP1 functions as an effector protein for the Ras family of GTPases, which are known to regulate a wide array of cellular functions. It is involved in the modulation of endothelial cell junctions and is critical for the proper formation of blood vessels (a process known as angiogenesis). RasIP1 achieves this by influencing the Rho GTPase signaling pathways, which are key regulators of the cytoskeleton and cell adhesion. Through its interaction with Ras and Rho GTPases, RasIP1 plays a vital role in transmitting signals that dictate cell shape, polarity, and movement, which are essential for the development and repair of tissues.
Structure[edit | edit source]
The structure of RasIP1 includes several domains that facilitate its interaction with other proteins, including the Ras and Rho families of GTPases. These interactions are critical for the protein's function in cell signaling pathways. However, the detailed structural aspects of RasIP1 and how these structures mediate its interactions with Ras and Rho GTPases are subjects of ongoing research.
Clinical Significance[edit | edit source]
Alterations in the RASIP1 gene or its protein product can have significant implications for human health. Given its role in angiogenesis, RasIP1 is of particular interest in the study of cancer, where abnormal blood vessel formation is a hallmark. Furthermore, its involvement in cell mobility and shape maintenance suggests potential roles in the progression of metastatic diseases. Understanding the function and regulation of RasIP1 could lead to new therapeutic targets for treating cancer and other diseases related to abnormal cell growth and differentiation.
See Also[edit | edit source]
 | This biology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
